MOHAMMED ISMAIL: Open Payments
NPI 1477588747 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 13 payments from 9 companies in 2025. Trend: 2023 $878 · 2024 $476 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $149 |
| Abbott Laboratories | 1 | $125 |
| Orexo US, Inc. | 2 | $43 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Indivior Inc. | 1 | $29 |
| Verona Pharma, Inc. | 1 | $26 |
| Braeburn Inc. | 1 | $23 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $23 |
Products named: Wegovy, JARDIANCE, FREESTYLE LIBRE 3, Zubsolv, REZDIFFRA, SUBLOCADE, Ohtuvayre, BRIXADI.
Industry payments across NY — which companies pay providers there.
